-->

TEST

Wednesday, 8 October 2014

Emerging opportunity in agri biotechnology : Hemang Baxi and Dr. Pranjivan Zaveri

H C Baxi
Consultant, Agri Biotech
Gujarat
Emerging opportunity in agri biotechnology

The biotech research and development toward genetic resistance to bollworm insect in the form of Bt cotton is regarded as a milestone to have an impact in raising the world production of this fibre crop besides reduction in use of deadly insecticides to the extent of 45–50%. It was done by transferring Cry Ac genes encoding the toxic crystal δ - endo toxin protein from the soil bacterium Bacillus thuringiensis for the first time by Monsanto of USA, which has the ability to control the bollworms during crop growth effectively. Use of this technology is also helpful in improving wild life population, reduced run-off of insecticides, reduced air pollution and improved safety to farm workers and neighbourhood. Much has been done to improve cotton as GMO by way of inserting many genes targeting insects. The efforts are underway all across the world to tape newer sources of resistance and other traits in several crops.

The agriculture biotech facts in 2013:

The Year 2013 is the 18th year of commercialization of biotech crops worldwide. Its commercialization confirmed the promise of biotech crops to deliver substantial agronomic, environmental, economics, health and social benefits to large- and small-scale farmers worldwide. The growth of biotech crops was from 1.7 million hectares in 1996 to 175.1 million hectares in 2013. 

In the last 18 years, millions of farmers in ~30 countries worldwide have made more than 100 million independent decisions to plant an accumulated hectarage of 1.6 billion hectares of biotech crops.

Of the 27 countries that planted biotech crops in 2013, nineteen were developing and eight were industrial countries. The five lead developing countries in Latin America (Brazil, Argentina), Asia (India, China)  and Africa (South Africa) grew 47% of global biotech crops.

Brazil is top among countries in 2013 to plant 40.3 million hectares of three biotech crops. Around 7.5 million farmers in China and 7.3 million farmers in India grew 15.2 million hectares of Bt cotton during 2013.
  
The top biotech crops in order of hectare are soybean, maize, cotton and canola, alfalfa, sugar beet, papaya, squash, poplar, tomato and sweet pepper in 2013.

Developing countries planted eight biotech crops in 2013 with accumulated hectarage of 91.1 million hectares. Bangladesh is the first country to grow GMO brinjal (eggplant).

Farmers from Latin America, Asia and Africa collectively grew 94.1 million hectares ( 54% of the global 175.2 million hectares) of biotech crops in 2013, compared with industrial countries at 81.1 million hectares ( 46% of the global total).

The top five countries planting biotech crops are USA, Brazil, Argentina, India and Canada. The USA continued to be the lead producer of biotech crops globally with 70.1 million hectares, and average adoption rate of 90% across all biotech crops. Biotech Canola had high adoption rate of 96% in 2013 in Canada.

In Africa, Burkina Faso and Sudan continued to make progress in increasing their Bt cotton hectarage in 2013, whereas South Africa maintained at 2.9 million hectares.

Five countries in the European Union planted 148,013 hectares of biotech maize in 2013. The countries are Spain (with high adoption rate of 31%), Portugal, Czech Republic, Romania and Slovakia.
Biotech crops helped 16.5 million farmers and their families in 2013 worldwide.

Biotech crops contribute to food security, sustainability and climate change. From 1996 to 2012, economic gains at the farm level of US$116.0 billion were generated globally by biotech crops, owing to reduced production costs and substantial yield gains.  Biotech crops have reduced the amount of pesticides used by 497 million kilograms. In 2012 alone, fewer insecticides spray reduced CO2 emissions by 26.7 billion kilograms, equivalent to taking 11.8 million cars off the road for a year.

The outlooks for biotech crops in the second decade of commercialization looks encouraging. These crops have the potential to make a substantial contribution to cutting poverty in half and optimizing crop productivity. Biotech crops can serve as engine of rural economic growth for the alleviation of poverty for the world’s small and resource-poor farmers.


Emerging technology requiring attention in biotechnology:

Climate change and its effect in agriculture
The continuing increase in greenhouse gas emissions raises the temperature of the earth’s atmosphere. This results to melting of glaciers, unpredictable rainfall patterns and extreme weather events. The accelerating pace of climate change, combined with global population and depletion of agricultural resources threatens food security globally.
The over-all impact of climate change as it affects agriculture was described by the Intergovernmental Panel on Climate Change (IPCC, 2007), and cited by the US EPA (2011) to be as follows:
  • Increases in average temperature will result to: i)  increased crop productivity in high latitude temperate regions due to the lengthening of the growing season; ii)   reduced crop productivity in low latitude subtropical and tropical regions where summer heat is already limiting productivity; and iii) reduced productivity due to an increase in soil evaporation rates.
  • Change in amount of rainfall and patterns will affect soil erosion rates and soil moisture, which are important for crop yields. Precipitation will increase in high latitudes and decrease in most subtropical low latitude regions—some by as much as about 20%, leading to long drought spells.
  • Rising atmospheric concentrations of CO2 will boost and enhance the growth of some crops but other aspects of climate change (e.g. higher temperatures and precipitation changes) may offset any beneficial boosting effect of higher CO2 levels. 
  • Pollution levels of troposphere ozone (or bad ozone that can damage living tissue and break down certain materials) may increase due to the rise in CO2 emissions. This may lead to higher temperatures that will offset the increased growth of crops resulting from higher levels of CO2.  
  • Changes in the frequency and severity of heat waves, drought, floods and hurricanes remain a key uncertain factor that may potentially affect agriculture.
  • Climatic changes will affect agricultural systems and may lead to emergence of new pests and diseases. 
Contribution of biotech crops in mitigating effects of climate change: 
Green biotechnology offers a solution to decrease green house gases and therefore mitigates climate change. Biotech crops for the last 16 years of commercialization have been contributing to the reduction of CO2 emissions. They allow farmers to use less and environmentally friendly energy and fertilizer, and practice soil carbon sequestration.
  • Herbicide-tolerant biotech crops such as soybean and canola facilitate zero or no-till, which significantly reduces the loss of soil carbon (carbon sequestration) and CO2 emissions, reduce fuel use and significantly reduce soil erosion.
  • Insect resistant biotech crops require fewer pesticide sprays that results in savings of tractor/fossil fuel and thus less CO2 emissions. For 2011, there was a reduction of 37 million kg of active ingredients, decreased rate of herbicide and insecticide sprays and ploughing reduced CO2 emission by 23.1  billion kg of CO2 or removing 10.2 million cars off the road.3 
Biotech crops adapted to climate change
Crops can be modified faster through biotechnology than conventional crops, thus hastening implementation of strategies to meet rapid and severe climatic changes. Pest and disease-resistant biotech crops have continuously developed as new pests and diseases emerge with changes in climate. Resistant varieties will also reduce pesticide application and hence CO2 emission.  Crops tolerant to various abiotech stresses have been developed in response to climatic changes.
Salinity-tolerant crops
Biotech salt-tolerant crops have been developed and some are in the final field trials before commercialization. In Australia, field trials of 1,161 lines of genetically modified  (GM) wheat and 1,179 lines of GM barley modified to contain one of 35 genes obtained from wheat, barley, maize, thale cress, moss or yeasts are in progress since 2010 and will run till 2015. Some of the genes are expected to enhance tolerance to a range of abiotic stresses including drought, cold, salt and low phosphorous. Sugarcane that contains transcription factor (OsDREB1A) is also under field trial from 2009 to 2015.
More than a dozen of other genes influencing salt tolerance have been found in various plants. Some of these candidate genes may prove feasible in developing salt tolerance in sugarcane, rice, barley, wheat, tomato and soybean.
Drought-resistant crops
Transgenic plants carrying genes for water-stress management have been developed.  Structural genes (key enzymes for osmolyte biosynthesis, such as proline, glycine/betaine, mannitol and trehalose, redox proteins and detoxifying enzymes, stress-induced LEA proteins) and regulatory genes, including dehydration–responsive, element-binding (DREB) factors, zinc finger proteins, and NAC transcription factor genes, are being used. Transgenic crops carrying different drought tolerant genes are being developed in rice, wheat, maize, sugarcane, tobacco, arabidopsis, groundnut, tomato, potato and papaya.
An important initiative for Africa is the Water Efficient Maize for Africa (WEMA) project of the Kenyan-based African Agricultural Technology Foundation (AATF) and funded by the Bill and Melinda Gates Foundation (BMGF) and Howard G. Buffet Foundations. Drought tolerant WEMA varieties developed through marker assisted breeding could be available to farmers within the next 2 or 3 years. Drought-tolerant and insect-protected varieties developed using both advanced breeding and transgenic approaches could be available to farmers in the later part of the decade. In 2012, a genetically modified drought tolerant maize MON 87460 that expresses cold shock protein B has been approved in the US for release in the market.
Biotech crops for cold tolerance
By using genetic and molecular approaches, a number of relevant genes have been identified and new information continually emerges. Among which are the genes controlling the CBF cold-responsive pathway and together with DREB1 genes, integrate several components of the cold acclimation response to tolerance low temperatures.
Cold tolerant GM crops are being developed such as GM eucalypti, which is currently being field tested in the US by Arborgen LLC since 2010. Thale cress has been improved to contain e DaIRIP4 from Deschapsia antarctica, a hairgrass that thrives in frosts down to -30C, and sugarcane are being introgressed with genes from cold tolerant wild varieties.

Biotech crops for heat stress
Expression of heat shock proteins (HSPs) has been associated with recovery of plants under heat stress and sometimes, even during drought. HSPs bind and stabilize proteins that have become denatured during stress conditions, and provide protection to prevent protein aggregation. In GM chrysanthemum containing the DREBIA gene from Arabidopsis thaliana, the transgene and other heat responsive genes such as the HSP70 (heat shock proteins) were highly expressed when exposed to heat treatment. The transgenic plants maintained higher photosynthetic capacity and elevated levels of photosynthesis-related enzymes.
Forward looking for biotech in climate change
Improved crops resilient to extreme environments caused by climate change are expected   in a few years to a decade. Hence, food production during this era should be given another boost to sustain food supply for the doubling population. Biotech research to mitigate global warming should also be initiated to sustain the utilization of new products. Among these are: the induction of nodular structures on the roots of non-leguminous cereal crops to fix nitrogen. This will reduce farmers’ reliance on inorganic fertilizers. Another is the utilization of excess CO2 in the air by staple crop rice by converting its CO2 harnessing capability from C3 to C4 pathway. C4 plants like maize can efficiently assimilate and convert CO2 to carbon products during photosynthesis.
Genetic engineering for nitrogen use efficiency (NUE):
Nitrogen is one of primary macronutrients that plants need for survival, aside from phosphorus and potassium. It is important for plant growth and development, particularly in metabolic processes such as production of nucleic acids, proteins and other helper molecules. It is a basic component of plant’s green pigment known as chlorophyll, which is vital for photosynthesis.  Nitrogen is abundant in the atmosphere but is not readily available for plants. It can be used up by plants when it is converted into ammonia from fixation by bacteria to make nitrogen-containing molecules.  
Biological nitrogen fixation occurs in some plants through metabolic activities of free-living or symbiotic bacteria. One common symbiotic bacterium involved in nitrogen fixation is known as Rhizobium which attacks and reproduces in the legume plants' roots to get their nutrition. After about a week of infection, white or grey nodules form in the roots. The bacteria through the action of the enzyme nitrogenase, convert the nitrogen gas (N2) into ammonia (NH3).
Since the discovery of nitrogen fertilizer, use of synthetic nitrogen has increased dramatically leading to significant boost in crop yields. However, only 30–50% of the applied nitrogen is absorbed by the plants and the wasted nitrogen cause considerable impacts on the environment. It can contribute to algal bloom and hypoxia (reduced oxygen in water) leading to significant loss of aquatic life and diversity and contribute to depletion of the ozone and global warming. Thus, scientists seek for more environment-friendly and cost-effective strategies to improve nitrogen use efficiency of crops. One of these strategies is to use genetic engineering.
Improving the nitrogen use efficiency of plants requires manipulation of several genes involved in nitrogen uptake, translocation and remobilization; carbon metabolism; signalling targets; and regulatory elements. Several genes (Table 1) from different sources have been found to control these processes and were investigated if the manipulation of the genes can lead to improved nitrogen use of plants. 
Table 1. Genes studied for improvement of nitrogen use
Gene(s) and source
Result(s)
Reference
nif genes
Klebsiella pneumoniae
activated nitrogenase function in Escherichia coli
GS1 
tobacco
enhanced grain yield and biomass as well as improved nitrogen content in wheat, tobacco and maize
AS1
Arabidopsis
improved soluble seed protein content, total protein content, and better growth in nitrogen-limiting medium
Dof1 
maize
improved growth under nitrogen limiting conditions as well as enhanced nitrogen assimilation
OsNADH-GOGAT1
rice
increase in spikelet weight of up to 80% in rice
AlaAT 
barley
production and degradation of alanine (functions as an intercellular nitrogen and carbon shuttle) in rice
STP13
Arabidopsis
improved plant growth and nitrogen use

Status of NUE crops
Corn
One of the crops under study for improvement of nitrogen use efficiency is corn, an important global food crop that requires intensive amount of nitrogen fertilizer. However, like most crops, corn only absorbs a small amount of the nitrogen that is applied to it, leading to economic problems to growers. In 2008, DuPont and Arcadia Biosciences announced that they have completed five years of multiple field trials of corn which resulted to improved nitrogen use efficiency and thus can lead to improvement in farm economics as well as environmentally positive effects. 
Wheat
In 2012, Australian Centre for Plant Functional Genomics (ACPFG) and Commonwealth Scientific and Ind­­­ustrial Research Organisation (CSIRO) announced their collaboration with Vilmorin & Cie in developing nitrogen use efficient wheat with the aim of reducing nitrogen fertilizer use in Australia. Developing NUE wheat will significantly impact 35% of the world population where wheat is a staple crop and represents 20% of the total protein intake.
CSIRO has applied for a licence for dealings involving 17 wheat lines and 10 line of barley, which have been genetically modified for improved nutrient utilization efficiency on a limited scale and under controlled conditions. 
Rice
Rice is the second largest crop and a staple for more than half of the global population. Arcadia Biosciences, African Agricultural Technology Foundation (AATF) and the International Center for Tropical Agriculture (CIAT) reported that in 2013, two years of field trials of nitrogen use efficient rice was completed in Colombia. The researchers integrated the nitrogen use efficiency technology with New Rice for Africa (NERICA) varieties developed by Africa Rice Center. Results of the trials showed that with an application of 50% of usual amount, the transgenic rice lines out-yielded the conventional NERICA variety by 22% on the first year of trial and 30% by the following year.
Canola
Canola is one of the world's most important oilseed crops. The seeds contain 44% oil, which is more than double the oil content of soybeans. Canola oil has heart-healthy characteristics and can also be used as biodiesel because of its exceptional cold weather performance. As of 2007, Arcadia Biosciences have completed five seasons of field trials of canola. The results of the trials showed that the canola plants had the same yield as the conventional varieties, but only half of the required nitrogen input was used. When the same amount of nitrogen with the conventional plants was used, the yield increased by about 15%.
Sugarbeet
SES VanderHave and Arcadia Biosciences have conducted three years of field trials to assess the yield performance of NUE sugar beet varieties. Results show that the experimental varieties produce higher yields than controls under various fertilizer applications over multiple years. They are now preparing regulatory data which will become available for all NUE technology licensees. 
Sugarcane
Sugarcane is cultivated to 25 million hectares worldwide, making it the world's largest sugar crop. Nitrogen fertilizer is an important factor in increasing the yields of sugarcane. South African Sugarcane Research Institute and Arcadia Biosciences announced in 2011 their collaboration in producing high-yielding sugarcane varieties that requires half the amount of the nitrogen fertilizer needed by conventional sugarcane varieties. 
Future Outlook on Nitrogen Use
A long-term tracer study revealed that 30 years after application of nitrogen fertilizer to agricultural soils in 1982, around 12–15% of the fertilizer-derived nitrogen was still residing in the soil organic matter, while 8–12% of the fertilizer had already leaked toward the groundwater. Part of the remaining nitrogen fertilizer present in the soil is predicted to continue to be taken up by crops and to leak toward the groundwater in the form of nitrate for at least another 50 years, much longer than previously perceived. The 13% with the development of nitrogen use efficient crops, environmental concerns such as what the study found out would be dispelled or at least reduced. At the same time, farmers would lessen economic losses for nitrogen fertilizer, and use their resources for other farm inputs or even more crop seeds to get more harvest.

References:

Clive James (2013) “Global Status of Commercialized Biotech/GM Crops: 2013”.
              http://www.isaaa.org/.

(References are being complied and will be added later)


Authors

Hemang Baxi
Agriculture Business Consultant. Working since last 24 years with Indian Agriculture input Industry. Working experience with DOW-Nocil, Plant Genes, Vikram Seed Ltd., (Now take up by Mahyco Group of Bombay).

Dr. Pranjivan Zaveri
CEO of Biogene Agritech, a company developing premium quality seeds.

Secretary of GSPA (Gujarat State Seed Producer Association)
read more

Thursday, 29 May 2014

GBIOFIN Student Partner Program

               
Applicable only if you still have more than 6 months of college remaining.


Nothing cool here. Just simple good old fashioned work. A lot of it. If you are ambitious, can solve problems rather than crib about them, if you can make a conversation with a stranger and if you understand the word "brand" and are keen on building one on campus...read on.

About the brand -

Founded by 3 Biopreneurs, GBIOFIN is the coolest and most successful Biotech awareness Firm in India.We strive to create an effective forum for Students and Various Organizations and Companies for Interaction.The GBIOFIN Group has a Mission to bring all the information related to Biotechnology under a single umbrella. Provide a complete platform for a biotech community to excel in thefield.
We provide various services to students . Check it out our various services - services@GBIOFIN

If you do not like processes, hate corporate type organizations; love creativity, innovation and fun at work; you will love it here.

Want to know more about us ??
Please take pain to visit -  Our website www.biofin.net
                                       Facebook Page
                                       Blog

About the program -

GBIOFIN Student Partner Program focuses on promoting the GBIOFIN Brand in
Universities and colleges  across India. The Student partners would be the strategic link between Campuses and GBIOFIN.

Work Profile-

Publicize GBIOFIN and its services in your college, both through Online and Offline Mediums.
Act as a Campus Contact for GBIOFIN Team.

Desired Skills-
The students in demand are the ones who are self-motivated and have good leadership skills.
Popularity on the campus would be a great add-on.
Why would you want to be a student partner for GBIOFIN
Exposure and experience to marketing and Brand building.
Monetary Benefit: Proportionate to the benefit you brought to the company (applicable only if you performs really well)
Develop soft skills, communication skills
Certificate of GBIOFIN in Association with BIOWEBSPIN (Swiss based Company) Appreciation
Chance to get a job/internship at GBIOFIN if you prove your mettle.
You start as student partner.
6 months you do an awesome job, you become a university head.
Another 6 months you become regional head (only 4 per city)  We will take you for meetings too then.
If you do well, you can become Zonal head - earning a good amount of handy cash and managing a team of 50+ under you.
Why you shouldn't apply

If you looking to just get another line on your CV
If you think its going to be easy and not much work
You just want to try it.
If you haven't visited our website yet and clicking the "apply here" link without even knowing about us.
And most important , Only biotech/life sciences/pharmacy background students are eligible.

If you have some doubts/queries regarding this program , please write to us – gbiofin@gmail.com
To apply for this program , please fill the online form available with this post
Last Date - 15th June 2014


https://docs.google.com/forms/d/13hq-oE3Ar_gLfS-t0Mjc_Ln3L-ATdGo-Eu9A6_KyJNk/viewform
read more

Wednesday, 12 March 2014

Interview : BiotechRings Magazine :Dr. A. Devi, an eminent scientist in stem cell research, shares her experiences and suggestions for young inspiring researchers


She is currently an Assistant Professor in SRM University and has her own research  laboratory, which is funded by agencies like DBT. She is the author to many papers in reputed international journals.

Having a PhD inZoology, what triggered your decision to pursue  research in cancer  and stem cell biology?

 I  completed my Ph.D. in Zoology, Madras University following which I was able to have an exposure  to all the avenues  in science amongst which Stem cell biol- ogy struck my cord  when  I completed post  doctoral fellowship from University of Alberta,  Canada.  I  further worked for over 2 years in MIOT hospital research centre  where  I  studied  the  ‘Use of fat pads  adopted from  patients  with  knee  replacement  surgeries   to cure  orthopedic non-disjunctions,  by selectively  dif- ferentiating  adipose  stem  cells to osteoblast cells for bone repair’. Currently, my lab focuses on a stem cells marker- Nucleostemin, Breast milk derived stem cells, cancer  biology  and  inter-correlation between  stem cells and phospholipids.

When you first started research,  the field of stem cells was still at nascent stage,  what were the hardships /challenges that you came across?

Lack of diversification in stem  cell research  and only a  handful  of people  really working  with  stem  cells, the start-up of my research  laboratory  was not easy. Mastering the culture of stem cells is the key to prolific results in stem cells research.  I would say, contamina- tion was the  biggest  hurdle. Maintenance  of a sterile environment with a responsibility of guiding scholars working takes time and practice.

Despite these  hardships what has been  your constant motivation that has helped  you to achieve so many accolades in this field?

Well, my family is the constant motivation  I have ever had.   Professionally,   the   co-operation  of  clinicians needed for collection of human  sample  for studies  is worth  mentioning.  I  am  grateful  to  all the  hospitals especially SRM medical College.

How has research in stem cells improved  in last couple of years? Further, where do you see the face of stem cells in the coming years?

During the last couple of years, a lot of focus on stem cell research  has opened up new areas  of interest  in this field. Researchers are looking for new sources from which we can avail continuous  supply of stem cells by procedures that are less invasive and painful. Research on identification  of stem  cell markers  and character- ization of the  different  types  of stem  cells has been the  important part  of stem  cell research  during  the last decade. However, use of stem cells for therapeutic approaches against  various diseases  like Alzheimer’s, Parkinson’s, diabetes and cancer  would be the centre of research  in the near future. A time would certainly come, when we can think of stem cell treatments than other treatments.

Could you please  elaborate on the current work being done in the field of stem cells worldwide  as well as in India?

Research   institutions  and  many  private  companies are involved in stem cell research  worldwide including India. BiorestorativeTherapies’,   a  life sciences  com- pany, has newly identified human adult brown fat cells and  developed a cell-based  treatment for diabetes. Their results have been  published  in the journal Stem Cells. The Stem  Cell Center  (Danstem),  University of Copenhagen, has recently shown the impact of phys- ical environment on embryonic  and  embryonic  stem cells (ESCs) on its specialization to different cell types. This understanding is an important step  toward  stem cell-based  cell therapies for conditions  like diabetes and liver diseases. Work on cancer stem cells has also gained  momentum in the  recent  years  as  it is well known that these cells play an important role in metas- tasis.  Recently, T cells with stem  cell like properties have been detected to play a role in resistance of HIV patients to  antiviral treatment. In addition  to  these,innumerable  studies  are being  conducted worldwide to identify new gene  targets for patients with differ- ent  disease  conditions  like Alzheimer’s and stem  cell replacement therapies for age related blindness. Work on the design of biomaterials  for bone  formation  has been studied in detail for bone defects  and bone met- abolic disorders.
In India, stem  cell banking  has established itself as a booming  industry, and a lot of private companies  are extending their service throughout India. The Council of Medical Research has given guidelines for clinical tri- als involving stem cells. Research laboratories of both private and governmental institutions are also actively involved in stem cell research.

We have heard  a lot about  Application of Stem cells in Medical field, e.g.stem cells was used for the treatment of legs of a 26/11 victim in  a Mumbai based  hospital who was completely paralyzed in the attack  , so is there  such other  application that has hap- pened in Medical field?

Talking about  stem cell therapy  treatments, they have been  used  in treating  heart  diseases  using patient’s own stem  cells; fetal brain stem  cells for Parkinson’s disease  have all been  carried  out with mixed results. Stem  cells have also been  used  to promote regener- ation  in various  organs  such  as the  brain and  bone. Stem  cell therapy  has also been  tried for Type I dia- betes   using  hESCs, MSC (mesenchymal stem  cells) in which the  cells are stimulated  to grow into β cells outside the body and are returned back to the patient. Recently, human embryonic stem cells have been used to target and destroy  cancer cells especially leukemia and  lymphomas.   Beside  cancer,  human  embryonic stem  cells have also been  used  as tool for the  treat- ment of various diseases such as diabetes,  Parkinson’s disease, Alzheimer’s disease  and heart  failure. Repair of the cornea  using stem cell therapy  has been highly successful. Research in NIH has tried treating  eye dis- eases  by  replacing  the  RPE (retinal  pigmented epi- thelium) cells and has developed a method to convert human  embryonic  stem  cells (hESCs) to differentiate into RPE cells. Bone disorders have been treated using osteoblasts derived from mesenchymal stem cells. However, though  some of these  have been successful, there is still a dilemma among  researchers whether  to continue research  on stem cells or to use it directly on patients.  Of course, more insights would increase  our knowledge on stem cells and surely help in better stem cell therapy  treatments. Many hospitals  in India also have  success  stories  in stem  cell therapy  treatments for diseases  such as thalassemia,  but  unless the  lay- man is able to gain the benefits of the treatment it can- not be accepted as a successful mode of treatment.

Besides SRM, what are the premier  orga- nizations/institutions/companies in India & Abroad that are working in Stem Cells? Please shed light.

In India, almost every renowned private hospital boasts of a stem cell research  laboratory, which in future will play a pivot  role in stem  cell therapy  treatment for the  patients.  Private  organizations like Life Cell are involved in stem cell banking in India, Manipal Institute of Stem cells and Regenerative Medicine, The Centre for Stem Cell Research  in CMC, Vellore supported by DBT, Government  of India, Vellore and The Institute for Stem Cell Biology (inStem), Bangalore, Nichi-In Centre for Regenerative Medicine (NCRM) is an institute affil- iated  with the Tamilnadu Dr. MGR Medical University, Madras  Medical  Mission Hospital  and  Frontier  Life Line Hospitals, The Nitte University Centre  for Stem Cell Research and Regenerative Medicine (NUCSReM) has set up a Stem Cell Research  Centre  in KS Hedge Medical Academy, Mangalore.
Internationally, a lot of government and private organi- zations are involved in stem cell research. A few import- ant ones are as follows—The International  Society for Stem  Cell Research  (ICCSR), The International  Stem Cell Forum (ISCF) The International  Society for Stem Cell Research  (ISSCR), Medical Research  Council (MRC). The UK Medical Research Council sponsors  the UK Stem Cell, Canadian Institutes  of Health Research (CIHR), EuroStemCell Eleven academic  institutes  and enterprises, Institute  for Frontier Medical Sciences Kyoto University, Centre for Stem Cell Biology as a part of the University of Sheffield.

What are your words of advice for the young minds aspiring to pick a career  in stem cell biology?

Understanding the  basics  of  Stem  Cell Biology,  its importance in the  scientific  field and  an  interest  in developmental biology  would  surely  be  an  asset  to the students who want to pursue  their career  in stem cell biology. For those  students, who  want  to  work and  contribute in research  areas  like cancer,  diabe- tes, heart  diseases,  stem  cell biology would prove  to be a right choice. Stem  Cell Banking and  counseling on stem  cells would be the other  option for students who want to pursue  their interest  in areas  other  than research.  All students should make it a point to read research  articles regularly and try to analyze and dis- cuss  the  papers  with their  friends  and  teachers and interact  in a Journal  Club to kindle their interest  not only in Stem Cell Biology but also other research areas of their interest. This interaction  will only help them to gain knowledge  and improve  their analytical skills to kindle their young minds.

From a student’s point of view, what are the career  prospects in stem cells?

Research would be the first option. For those not interested  in research,  now-a-days counseling  and  stem cell banking centers  also serve as a career  point and they  can  actively develop  a career  in counseling  on stem cells and banking to the common  people. Since, stem cell research  is a part and parcel of all hospitals; students may opt  for a career  in stem  cell laboratories serving as a bridge between the patients and the doctors. Students can involve in culturing of stem cells for therapy  treatments in hospitals after taking proper training in animal cell culture techniques.
read more

Monday, 10 March 2014

Post of Drug Safety Physician at Accenture

Accenture is a global management consulting, technology services and outsourcing company, with approximately 275,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world's most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments.
Job Title : Drug Safety Physician
Job Id : J1715
Job Description :
  • Reviewing medical literature, safety data, draw conclusions from safety reports, clinical reports, proficiency in medical report writing and safety standards. Clinical Review of all cases - serious and non-serious safety reports
Responsibilities/Authorities :
  • Reviews and verifies appropriate selection of adverse events from source documents, appropriate code for each adverse event and accuracy of label assessments for each adverse event. Adjust to changing regulatory environment.
  • Provides a medical evaluation comment for all serious spontaneous, unlisted adverse events and serious related events from studies and solicited adverse events
  • Provides assessment(s) for study cases and solicited reports.
  • Reviews the source document to assure relevant information pertaining to the case is appropriately entered
Requirements:
  • No special physical demands.
  • Major part of work done in office environment.
  • High degree of accuracy and attention to detail.
  • Previous computer experience.
  • Skill in Medical Writing
  • Ability to read and interpret AE cases and medical literature, draw conclusions, and draft aggregated reports.
  • Knowledge of Medical Safety Standards.
Desired Profile :

Education : Ph.D. in Life Sciences or Pharmacy/M.D. in Pharmacology or Physiology or Human Genetics
Experience : 4 to 7 years of relevant experience. Prior team leading experience of at least 1 to 2 years is required.
How to Apply :

Interested candidates can apply online using the link below :
http://careers.accenture.com/in-en/jobs/Pages/jobdetails.aspx?lang=inenServices&job=J1715
 
read more

Monday, 10 February 2014

Complete Chemical Synthesis of DNA- Thanks to Click Chemistry

Dr Ali Tavassoli, a Reader in chemical biology at the University of Southampton, along with his collaborators, Dr Jeremy Blaydes and Professor Tom Brown, has lead an interdisciplinary study that assembles DNA which is functional in human cells using click chemistry. A linker has been used to stitch DNA strands together. Human cells can still read through this DNA correctly irrespective of the fact that linker used was not found in nature. This finding has opened doors to the possibility of total chemical synthesis of DNA.

Click chemistry functions like nature to generate substances quickly by joining small units together. Oligonucleotides were joined together to create artificial DNA using click chemistry. The usual approaches to assemble DNA strands comprises of  DNA synthesis, PCR amplification and enzymatic ligation. Click technique has several advantages over these usual techniques apart from being greatly efficient.
DNA is a strand of nucleotides that are attached together using phosphodiester bond, with the help of pentose sugars and phosphate groups. According to Dr Tavassoli, chemists had always assumed this phosphodiester bond to be essential for DNA functioning in the cell. However, in recent study using click technique, Modified DNA strands were stitched together rapidly and efficiently using the copper-catalysed alkyne-azide cycloaddition reaction. Click-linking DNA leaves behind a triazole group in the backbone and it was feared that cellular machinery would be unable to read these unnaturally joined DNA strands. However, the new study demonstrated error-free transcription in human cells, the first example of a non-natural DNA linker working correctly in eukaryotic cells.

This discovery not only gives an alternative to enzymatic methods for DNA assembly, but also suggests that we don't have to stick to the phosphodiester backbone of the DNA at the site of DNA ligation.
read more

Sunday, 9 February 2014

Walk in Interview for research scholars at ILS, Bhubaneswar

The Institute of Life Sciences (ILS), an autonomous institute has been brought under the fold of the Department of Biotechnology, Government of India in August 2002. The institute is located in close proximity to other research institutions at Bhubaneswar. The institute was earlier established on February 11, 1989 and was under the administrative and financial control of Department of Science and Technology, Government of Orissa. Prime minister of India dedicated the institute to the nation on July 15, 2003 with a declaration to develop the institute as a "National Centre for Excellence".
Eligible and interested candidates can appear for the walk-in-interview for JRF/SRF/RA at ILS, Bhubaneswar

  • Position title : JRF/SRF/RA
  • Project title : “Enhancement of yield potential of rice cultivars by application of Invinsa (1-methylcyclopropene), an ethylene action inhibitor ” 
  • Duration : Co-terminus with project but not less than six months.
  • Fellowship : Rs.18000/- plus @ 20% HRA or as per suitability (In case of deserving candidates the fellowship may be fixed at higher level)
  • Desired Profile : M. Sc in Botany/Life Sciences/Agriculture/ Biotechnology. Preference will be given to candidates having working experience in field based rice related project evidenced by publications in journals of international repute. Interested and eligible candidates may apply with detailed bio-data to Director, Institute of Life Sciences, Nalco Square, Bhubaneswar-23 or by email to academic@ils.res.in on or before last date. Short-listed candidates called for interview will have to submit self-attested copies of their educational qualification and experience certificates along with original for verification on the date of interview, failing which, the candidate will not be interviewed. The position is purely temporary and co-terminus with project. The candidates will not have any right to claim (explicit or implicit) to any post in the Institute. No interview letter will be sent separately. No TA & DA will be paid for attending the interview. The decision of the Director regarding selection of the candidates will be final and no correspondence will be entertained in this regard. Prospective candidates may visit the institute website: www.ils.res.in.
    Deadline : 12.02.14
SOURCE: Click here!
read more

JRF Post at NICED, Kolkata

The vision, of the National Institute of Cholera and Enteric Diseases (NICED), is to perform research and develop strategies for treatment, prevention and control of enteric infections and HIV/AIDS threatening the Nation’s health.
The following post will be filled up on purely temporary basis under the project entitled “Anti-diarrheal mechanism of Zinc: Effect on epithelial ion transport and barrier function” under Dr. Mirajul Hoque Kazi, Ramalingaswami Fellow & P.I. of the project:

  • Position title : JRF
  • No of Post : One
  • Fellowship : Rs. 16,000/- p.m. Plus 30% HRA
  • Desired Profile : M.Sc. First Class in Life Sciences/Physiology/Biochemistry/Biotechnology with CSIR/UGC NET/DBT/ICMR JRF Qualified.
  • Age : Below 28 years
  • Candidates fulfilling the above criteria may report to the Administrative Officer, along with Bio-data showing academic record from Matriculation onward experience, recent passport size photograph and attested copies of relevant certificates.
    Address:
    National Institute of Cholera & Enteric Diseases
    (JICA Building within ID & BG Hospital Campus)
    P-33, C.I.T. Road, Scheme-XM, Beliaghata,
    Kolkata- 700 010
    Deadline : 21.02.14
Source: click here!
read more

Friday, 31 January 2014

Multiple openings for various positions in different project at CIMAP, Lucknow

Central Institute of Medicinal and Aromatic Plants, popularly known as CIMAP, is a frontier plant research laboratory of Council of Scientific and Industrial Research (CSIR). Established originally as Central Indian Medicinal Plants Organisation (CIMPO) in 1959, CIMAP is steering multidisciplinary high quality research in biological and chemical sciences and extending technologies and services to the farmers and entrepreneurs of medicinal and aromatic plants (MAPs) with its research headquarter at Lucknow and Research Centres at Bangalore, Hyderabad, Pantnagar and Purara.
Eligible and interested candidates may attend the Interview for engagement on purely temporary basis as Project Assistants of different level/JRF-Projects/ Research Associate (Projects) on contract basis in the Projects under CSIR Network Scheme, Grant-in-aid Projects and other projects sponsored by Govt. Agencies tenable at CSIR-CIMAP, Lucknow in various disciplines detailed as under:
  • Position : PA II or JRF
  • No of Post : One
  • Age Limit : 28 years
  • Desired Profile : PA : First class M. Sc. (Ag.) in Genetics Plant Breeding / Plant Breeding / Horticulture/ Plant Physiology AND for JRF : First class M. Sc. (Ag.) with Net LS in Biotechnology / Biotechnology Plant Sciences / Ag. Botany / Botany.
  • Stipend : For PA II : Rs. 12000/- pm (consolidated) or For JRF Project Rs. 14000/- + HRA pm
  • Position : PA II or JRF
  • No of Post : One
  • Age Limit : 28 years
  • Desired Profile : PA : First class M. Sc. In Chemistry/ Pharmaceutical Chemistry/ M. Pharma. or For JRF : First class M. Sc. (Ag.) with Net LS In Chemistry/ Pharmaceutical Chemistry/ M. Pharma
  • Stipend : For PA II Rs. 12000/- pm (consolidated) or For JRF Project Rs. 14000/- + HRA pm 
  • Position : PA II
  • No of Post : Two
  • Age Limit : 28 years
  • Desired Profile : M. Sc.in Biochemistry/Biotechnology / Molecular Biology/ Microbiology/ life sciences.                                            
  • Experience : Person having working  experience on Caenorhabditis elegans model will be given  special preference
  • Stipend : Rs.10000/-pm   (consolidated)
  • Position : PA II
  • No of Post : One
  • Age Limit : 28 years
  • Desired Profile : First class M. Sc.in Biotechnology/Biochemistry/Molecular Biology/Life Science
  • Stipend : Rs.12000/-pm   (consolidated)
  • Position : JRF/SRF
  • No of Post : One
  • Age Limit : 32 years
  • Desired Profile : For JRF : First class M. Sc.  with Net LS in Biotechnology/Biochemistry/Life Science/Botany or For SRF : First class M. Sc. with Net LS and two years experience as JRF Project  in Biotechnology/Biochemistry/Life Science/Botany                                      
  • Position : RA
  • No of Post : One
  • Age Limit : 35 years
  • Desired Profile : Ph.D in Microbiology (Ph.D awarded as on date of interview).  
  • Experience : Wet lab and in silico experience in molecular interaction studies to identify antimicrobial phytomolecules 
  • Stipend : For JRF: Rs 12000/-  
  • Position : PA II
  • No of Post : One 
  • Age Limit : 28 years
  • Desired Profile : First class M. Sc. in Biotechnology/Botany/ Agricultural sciences/Genetics 
  • Stipend : For JRF: Rs 12000/-
For Project Assistants Level-I/II/III, the upper age limit as mentioned for all the above positions will be as on Date of Interview(Dated 12-02-2014 Reporting Time 9.30AM) which is relaxableupto 5 years in the case of candidates belonging to scheduled Caste/Scheduled Tribes/Persons with disabilities and 3 years for OBC candidates. Interested candidates may appear before the committee on the date and time mentioned as above for the respective area/Project in the Auditorium of the Institute for interview alongwith their signed Bio-Data on prescribed proformaalongwith original and attested copies of marksheets/certificates and a recent passport size photograph. No TA will be admissible. 
Deadline : 12.02.14
read more